Plus Therapeutics Inc (PSTV)

HEALTH CARE: PHARMACEUTICALS
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

4200 MARATHON BLVD. AUSTIN, TX 78756

Discovers and develops proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat tissue. The company expects to begin clinical trials in 2006. It also makes bioresorbable surgical implants.

Data as of 2021-05-08 10:36:20 -0400
Market Cap45.8 Million Shares Outstanding21.106 Million Avg 30-day Volume2.173 Million
P/E Ratio-4.63849 Dividend Yield EPS-1.79
Price/Sales247.57 Debt to Equity1.93 EBITDA-8.481 Million
Price to Book Value4.81 Forward PE-1.64 Enterprise Value37.839 Million
Total Cash14.447 Million Current Debt8.315 Million Gross Profit185 Thousand
BETA1.06987 52-week High/Low5.42 / 1.59 Next Earnings Date2021-07-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from PSTV instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PSTV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PSTV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.2 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HEDRICK MARC H CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
18,580 2021-04-30 8

CLOWES HOWARD

  • Director
3,000 2021-03-03 2

SIMS ANDREW JOHN HUGH MACINTYRE CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-16 1

LENK ROBERT P

  • Director
3,000 2020-08-25 2

PETERSEN GREG

  • Director
20,000 2020-08-13 2

HAWKINS RICHARD J

  • Director
0 2020-06-25 1

VAN ES-JOHANSSON AN

  • Director
0 2020-06-25 1

GIRAO TIAGO VP & CHIEF FINANCIAL OFFICER

  • Officer
0 2018-07-25 0

POSTFINANCE AG

  • 10% Owner
No longer subject to file 2018-02-14 0

SWISSQUOTE BANK SA

5,328,229 2018-01-09 0

RICKEY DAVID

  • Director
0 2017-11-28 0

LYONS GARY A

  • Director
0 2017-11-28 0

NAUGHTON GAIL K

  • Director
0 2017-11-28 0

HARRIS JOHN DAVID VP AND GM CELL THERAPY

  • Officer
0 2017-11-28 0

LAPOINTE ANTHONY GREGG

  • Director
0 2017-05-22 0

HAYDEN JEREMY B. GENERAL COUNSEL & VP OF BD

  • Officer
0 2017-03-08 0

MARINO MARK CHIEF MEDICAL OFFICER

  • Officer
0 2017-03-08 0

HAWRAN PAUL W

  • Director
0 2017-01-26 0

MARTELL RON

  • Director
0 2017-01-26 0

KESTEN STEVEN EXEC VP AND CHIEF MO

  • Officer
3,881 2016-06-15 0

THOMPSON TOMMY G

  • Director
0 2016-01-04 0

LIM KIAN THIAM

  • 10% Owner
No longer subject to file 2015-04-06 0

SHIRAHAMA NORIO SEIJIRO PRESIDENT - ASIA PACIFIC

  • Officer
48,659 2015-01-30 0

TOWNSEND JOHN CONTROLLER

  • Officer
1,645 2015-01-30 0

JONA RUUD J.P.

  • Director
0 2014-06-07 0

DEAN LLOYD H

  • Director
91,059 2014-05-19 0

HOLMES E CARMACK

  • Director
56,918 2014-05-19 0

SAAD MARK E CHIEF FINANCIAL OFFICER

  • Officer
138,430 2014-04-11 0

CALHOUN CHRISTOPHER J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
154,975 2014-01-10 0

HENRIKSEN RONALD D

  • Director
70,092 2012-01-01 0

ARM DOUGLAS M SR. VP - OPERATIONS

  • Officer
0 2009-04-30 0

REUTER BRUCE SVP SALES, MARKET., DISTR.

  • Officer
0 2009-01-29 0

MILSTEIN ALEXANDER M VP - CLINICAL DEVELOPMENT

  • Officer
0 2009-01-29 0

OLYMPUS CORP

  • 10% Owner
4,013,043 2008-08-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HEDRICK MARC H - Director - Officer CHIEF EXECUTIVE OFFICER

2021-05-03 06:15:08 -0400 2021-04-30 P 2,183 $2.28 a 18,580 direct -7.6923 0.0 1 -7.6923 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PLUS THERAPEUTICS INC PSTV 2021-05-10 22:15:04 UTC -78.2986 78.3486 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 21:45:02 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 21:15:02 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 20:45:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 20:15:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 19:45:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 19:15:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 18:45:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 18:15:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 17:45:02 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 17:15:03 UTC -78.2765 78.3265 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 16:45:03 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 16:15:03 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 15:45:03 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 15:15:03 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 14:45:04 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 14:15:04 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 13:45:04 UTC -78.4912 78.5412 200000
PLUS THERAPEUTICS INC PSTV 2021-05-10 13:15:03 UTC -78.4912 78.5412 45000
PLUS THERAPEUTICS INC PSTV 2021-05-10 12:45:02 UTC -78.4912 78.5412 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments